Blog

Category: PBC News

PBC News
Combination Therapy works for PBC

Study concludes that triple therapy with UDCA, OCA and fibrates is able to normalise biochemical liver tests and improve pruritus in patients with difficult‐to‐treat PBC. 

PBC News
OCA real world experience

Since OCA (Ocaliva) was approved in the US in 2016 and Canada in 2017, there have been several  studies to assess its effectiveness in PBC

PBC News
CaNAL Patient Registry Update

The Canadian Network for Autoimmune Liver disease (CaNAL) is a longitudinal observational cohort study of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH),

Clinical Trials
Elafibranor ELATIVE study now enrolling

The Phase 3 study will consist of Elafibranor 80mg for double blind period (52 to 104 weeks). After completion of the double blind period, participants

PBC News
EL-FIT program helps keep liver patients fit!

El-Fit offers a custom exercise program, tailored to meet the individual needs of liver patients.  Using a friendly APP, the program allows patients to set